The mutation-dependent pathogenicity ofNPHS2p.R229Q: A guide for clinical assessment

Authors:

Abstract
NPHS2, encoding podocin, is the major gene implicated in steroid‐resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation‐dependent pathogenicity: it is only pathogenic when trans‐associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African and Latino populations, its benign trans‐associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q‐associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q‐association can be considered pathogenic if the variant in trans meets the following criteria: it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q‐association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (15% of the p.R229Q associations identified so far in patients are benign. This article is protected by copyright. All rights reserved
Funding Information
  • Emberi Eroforrások Minisztériuma
  • Seventh Framework Programme (2012-305608)
  • Magyar Tudományos Akadémia (MTA-SE Lendulet Research Grant (LP2015-11/2015), MedinProt Synergy Grant (DKM, KT))
  • Nemzeti Kutatási és Technológiai Hivatal (K109718, K116305, KH125566, EFOP-3.6.3-EKOP-16-2017-00009)
  • Agence Nationale de la Recherche (ANR-10-IAHU-01, ANR-12-BSV1-0033.01)

This publication has 27 references indexed in Scilit: